Saturday, August 01, 2020 10:05:39 AM
The management's compensation has three part (examples are re. JT (before taxes):
(i) base salary: at levels near the 50th percentile of salaries of executives with similar roles at the peer group and the adjustments are considered annually ($700,000, effective February 1, 2019 - in fiscal year 2019: $697,067 - and is below the 25th percentile for Chief Executive Officers within peer group)
(ii) annual and short-term incentive (cash) bonuses (Target: 75% of base compensation - slightly below the 50th percentile for other Chief Executive Officers in peer group - in case of 100% achievement of corporate goal. The achievement of base corporate goals was 121% in 2019 resulted in $635,250 bonus)
(iii) equity awards (RSUs and Options ... are subject to both time-based and performance-based vesting criteria)
In 2019 it was 8% (i), 9% (ii) and 85% (iii) ... (Total cash - (i) + (ii) - was $1,332,317 or $111,026 / month)
Equity awards
They got award (a) annually (once a year ... RSUs and Options) and (b) occasionally.
The (a) is time-based (usually) and the RSUs vest in three equal installments on a yearly basis meanwhile the Options vest and become exercisable in 16 equal quarterly (or 48 monthly) installments.
The (b) is performance-based or performance- and time-based.
In 2020 (YTD):
Awards:
- RSU: 178,100 (will west in 2021, 2022 and 2023, 59,367 / year)
- Option: 350,700 (will vest and become exercisable in 16 equal quarterly installments starting on April 30, 2020) with $18.39 exercise price. The value of this is $00.00 currently.
Vested (625,228 RSUs / 375,005 after withholding by the Issuer of shares in respect of tax liability these are not awards, were granted in previous years, is not in 2020)
(1) 315,367 RSUs. (187,080 after withholding by the Issuer of shares in respect of tax liability)
The annual vest of the 2017, 2018 and 2019 annual, one-time RSU award / grant (1/3 of the total award).
(2) 309,861 RSU (187,925 after withholding by the Issuer of shares in respect of tax liability)
970,000 RSUs was granted on May 15, 2017 (25%, 25% and 50% tranches. Each tranche vests ratably over 36 months beginning Sept. 30, 2018 subject to achievement of certain prespecified performance criteria and continued employment).
The performance criteria - is or including audited net total revenue for 2019 - related to both 25% tranches was deemed to be achieved, resulting in the vesting of 114,515 RSUs per tranche (970,000 * 25% / 36 * 17 per tranche). The remaining RSUs in these two tranches will continue to vest over 19 monthly installments. (6,736 and 6,736 each of them … it is the recent Form-4. We see it since February and will see till August, 2021 … but (it is not a 2020 / recent award ) The performance criteria related to the 50% tranche has not yet been achieved
Best,
G
Disclosure: I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.
Recent AMRN News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:30:10 AM
- Amarin Board of Directors Announces CEO Transition • GlobeNewswire Inc. • 06/04/2024 11:30:00 AM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM